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doi:10.1016/j.ejvs.2009.09.005Abstract Angio-Seal is a frequently used vascular closure device after arterial catheterisa-
tion. Major complications are infrequently reported. We present four cases occurring within
a 2-month period in our hospital with dislodgement of an Angio-Seal causing acute arterial
occlusion, resulting in loss of limb in one case.
Surgical intervention was necessary in all cases. Acute arterial occlusion after deployment of
the Angio-Seal in patients with peripheral arterial disease might be less uncommon than the
literature suggests.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Manual compression has been the traditional means of
haemostasis after femoral artery catheterisation. Compli-
cations range from 1% to 5%, including haematoma,
bleeding, arteriovenous fistulae and pseudoaneurysms.1
This led to the development of vascular closure devices
(VCDs). Advantages over manual compression include
reduced haemostasis time, quicker ambulation, improved31 243615333; fax: þ31
hir.umcn.nl (H.J.J. van der
ty for Vascular Surgery. Publishecomfort, earlier discharge and fewer complications.1e3 One
of these devices, Angio-Seal, is composed of an absorbable
collagen sponge and a specially designed absorbable poly-
mer anchor connected by an absorbable self-tightening
suture. The device seals and sandwiches the arterial wall
between the anchor and sponge.
Notwithstanding the favourable reports, application of
Angio-Seal is not without complications. In this article, we
present four patients in whom the use of Angio-Seal has
resulted in acute arterial occlusion and amputation in one
case due to dislodgment of the device.d by Elsevier Ltd. All rights reserved.
Figure 2 Peroperative picture of intimal destruction of the
left CFA, with an intraluminal Angio-Seal, as the cause of
arterial occlusion.
716 H.J.J. van der Steeg et al.Case Reports
We perform approximately 1500 angiographies per year. In
half of those a VCD is deployed, mainly Angio-Seal, result-
ing in a total of 600 Angio-Seals. Our selection criteria for
the use of a VCD are:
<5 Fr sheath: manual compression;
5,6,7 Fr sheath: Angio-Seal;
8,9 Fr sheath and/or thrombolysis: Perclose; and
10 Fr sheath: Prostar.
We report four cases of complications with the Angio-
seal, which occurred in a 2-month period. About a hundred
Angio-Seals were used during that period.
Case 1: A 50-year-old woman presented with persistent
left calf pain 8 days after a subintimal angioplasty of the
right superficial femoral artery (SFA) by a crossover tech-
nique with Angio-Seal closure of the left groin. Duplex
scanning showed occlusion of the left SFA. After unsuc-
cessful thrombolysis (Fig. 1), surgical exploration showed
an intraluminal disrupted Angio-Seal at the femoral bifur-
cation. After device removal, thrombectomy was per-
formed. Wound infection led to repeated surgery with an
eventual construction of an iliacofemoral bypass.
Case 2: A 61-year-old man presented with acute left leg
ischaemia 3 days after percutaneous transluminal angio-
plasty (PTA) of the right deep femoral artery by a crossover
technique. Angiography showed occlusion of the left
common femoral artery (CFA). During surgical des-
obstruction, the anchor of an Angio-Seal was recovered
from the lumen of the CFA (Fig. 2). Despite a femorocrural
bypass 5 days later, ischaemia progressed, thus requiring an
above-knee amputation.
Case 3: A 65-year-old man complained of pain in the
right leg 1 day after PTA of the superior mesenteric arteryFigure 1 Angiography preceding thrombolysis showing an
acute arterial occlusion of the left proximal SFA due to
dislodgment of the Angio-Seal.for ischaemic enteritis through a right groin access with
Angio-Seal closure. Angiography showed an occluded CFA.
Thrombolysis was unsuccessful. The Angio-Seal was
extracted from the CFA lumen during endarterectomy. The
patient made an uneventful recovery.
Case 4: An 80-year-old woman complained of acute
ischaemia of the right foot 1 day after subintimal angio-
plasty of the right SFA accessed through the right groin and
closed with Angio-Seal. At surgical exploration, a complete
closure device was extracted from the lumen of the
femoral bifurcation. After thrombectomy and additional
thrombolysis, she made an uneventful recovery.
Discussion
Extensive experience with VCDs has been reported in
cardiological randomised trials. Two recent meta-analyses,
however, show that the overall reported advantages of
VCDs over manual compression should be interpreted
cautiously.4,5 This is mainly caused by concern over the
quality of the published trials.4 In addition, studies ana-
lysing mixed diagnostic and interventional procedures show
significant heterogeneity in complication rates.5 A meta-
analysis of all included studies in mixed settings and all
other settings together favoured conventional compression
technique over VCD.5
Few studies have been reported on the use of Angio-Seal
in peripheral arterial disease (PAD). In a non-randomised
study by Abando et al., Angio-Seal was used for femoral
artery closure in 188 patients.1 There were two complica-
tions related to device deployment (0.9%). One patient
developed a false aneurysm. A second patient required
operation for vessel occlusion after device deployment in
a markedly diseased femoral artery. To minimise adverse
events, these authors suggested several guidelines for the
use of Angio-Seal in patients with PAD; for example,
the device should not be used if the puncture site is above
the inguinal ligament or below the femoral bifurcation or in
case of small (<5 mm) or diseased arteries. The basis for
these guidelines is yet unclear. These recommendations
have nonetheless been included in the manufacturers’
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MediaAssets/documents/usifu41499.pdf).
Major complications following the use of Angio-Seal, such
as infection and acute arterial occlusion, occur in 0.5e1.9%
of cases.1 Despite these low complication rates, we
encountered four serious complications in 2 months. In our
hospital, 1500 angiographies are performed yearly, using
a total of 600 Angio-Seals. Our two interventionalists both
have over 4 years of experience with Angio-Seal and have
received initial training by the manufacturer. In the scope of
good clinical practice, these complications have urged us to
analyse them thoroughly. We could not identify a specific risk
factor that could explain the technical problems encoun-
tered. We conferred with several experienced colleagues in
the field, who somewhat surprisingly confirmed our negative
experiences. Regarding this discrepancy between the
favourable results in the literature and the less favourable
experiences in clinical practice of patients with PAD,
a publication bias is likely.
We would like to emphasise that using Angio-Seal for
immediate haemostasis in patients undergoing interven-
tional procedures for PAD is not without risk of serious
ischaemic complications. Acute arterial occlusion might be
less uncommon than the literature suggests.Conflict of Interest/Funding
None.
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